{"meta":{"query_hash":"b035e4c0f8a1","filters":{"venue":"Frontiers in Drug Discovery"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b035e4c0f8a1","api":"https://metacan.xera.ac/api/v1/cohort?venue=Frontiers+in+Drug+Discovery"},"results":[{"id":"W4281288416","doi":"10.3389/fddsv.2022.892975","title":"Addressing Antibiotic Failure—Beyond Genetically Encoded Antimicrobial Resistance","year":2022,"lang":"en","type":"article","venue":"Frontiers in Drug Discovery","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NanoMedicines Innovation Network; BC Innovation Council; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Antibiotics; Antibiotic resistance; Intensive care medicine; Sepsis; Medicine; Biology; Immunology; Microbiology","score_opus":0.008062339948502634,"score_gpt":0.23107999692585765,"score_spread":0.223017656977355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281288416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865946,0.001558282,0.006237622,0.0003676833,0.0017503805,0.00033052976,0.0001614489,0.00002243086,0.0029770262],"genre_scores_gemma":[0.9733547,0.00016505376,0.019318732,0.00047351595,0.00022688377,0.00001141011,0.00026198744,0.000062958396,0.0061247805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976236,0.00025942372,0.00044638728,0.0007781061,0.00031985735,0.00057258335],"domain_scores_gemma":[0.99902153,0.000014640047,0.00017593426,0.0006754067,0.000034202836,0.000078305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036102612,0.00028726686,0.00034629946,0.00014519817,0.00027593327,0.00013769449,0.0006579214,0.000110807654,0.000033488304],"category_scores_gemma":[0.000079502766,0.00032452273,0.00014920949,0.00029913476,0.0002767233,0.000027825254,0.0004941846,0.0002979319,0.0000039795336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008759819,0.00028899423,0.11281608,0.00013180106,0.00010047848,0.000112321475,0.00020149647,0.0012983353,0.53602755,0.00024360666,0.3474802,0.00042312514],"study_design_scores_gemma":[0.0070187617,0.00041547554,0.078758076,0.00052980514,0.00018346937,0.00012331332,0.00589365,0.00050041126,0.68733114,0.0023420674,0.21295467,0.003949179],"about_ca_topic_score_codex":0.000016578437,"about_ca_topic_score_gemma":0.00014316705,"teacher_disagreement_score":0.15130354,"about_ca_system_score_codex":0.0001337507,"about_ca_system_score_gemma":0.00023504454,"threshold_uncertainty_score":0.99992067},"labels":[],"label_agreement":null},{"id":"W4281556573","doi":"10.3389/fddsv.2022.898654","title":"Overcoming Market Failures in Pandemic Drug Discovery Through Open Science: A Canadian Solution","year":2022,"lang":"en","type":"article","venue":"Frontiers in Drug Discovery","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Structural Genomics Consortium; University of Toronto; McGill University","funders":"","keywords":"Pandemic; Business; Private sector; Incentive; Variety (cybernetics); Investment (military); Drug development; Market failure; Coronavirus disease 2019 (COVID-19); Public relations; Public economics; Industrial organization; Economics; Economic growth; Drug; Political science; Market economy; Pharmacology; Infectious disease (medical specialty); Medicine","score_opus":0.031947902120840796,"score_gpt":0.27624080807343865,"score_spread":0.24429290595259784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281556573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8485042,0.0036078289,0.00062767084,0.006587354,0.00424293,0.0009822652,0.0016449124,0.000024397848,0.13377845],"genre_scores_gemma":[0.9903434,0.0005340468,0.0006048325,0.0031269891,0.0001010111,0.00017585506,0.000042215706,0.00003719937,0.0050344416],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970957,0.0000804162,0.0008143024,0.0008893111,0.00009681923,0.0010234381],"domain_scores_gemma":[0.9989642,0.000063068364,0.0002606849,0.0005084928,0.000008731577,0.00019482322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026381013,0.00025078497,0.00059860724,0.0010624717,0.0005081976,0.00079877424,0.0019437515,0.000059915743,0.00036501468],"category_scores_gemma":[0.00013498134,0.0003268537,0.00012138726,0.001069454,0.00028420176,0.00430248,0.0012408582,0.00062471296,0.000026270303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001517926,0.00017863128,0.6962614,0.000031856744,0.000040302068,0.000030564388,0.003129507,0.0031144454,0.000018010589,0.10236834,0.19397831,0.00069682905],"study_design_scores_gemma":[0.0030154593,0.000033232358,0.07490181,0.00005648072,0.0000101819705,0.000011405095,0.0037689835,0.030814148,0.000059362337,0.23512453,0.6509868,0.0012176012],"about_ca_topic_score_codex":0.29398006,"about_ca_topic_score_gemma":0.10873166,"teacher_disagreement_score":0.6213596,"about_ca_system_score_codex":0.003775787,"about_ca_system_score_gemma":0.000855632,"threshold_uncertainty_score":0.99991834},"labels":[],"label_agreement":null},{"id":"W4389479264","doi":"10.3389/fddsv.2023.1346042","title":"Editorial: Drug discovery for emerging and neglected tropical diseases: advances, challenges and perspectives","year":2023,"lang":"en","type":"editorial","venue":"Frontiers in Drug Discovery","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Neglected tropical diseases; Drug discovery; Tropical disease; Data science; Medicine; Biology; Computer science; Bioinformatics; Disease; Pathology","score_opus":0.00747027213654267,"score_gpt":0.26981813955534245,"score_spread":0.2623478674187998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389479264","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017413978,0.20465724,0.0002687754,0.00038731165,0.79017437,0.00046184595,0.0021403322,0.000096980606,0.000071742834],"genre_scores_gemma":[0.0014777043,0.15498686,0.0001600289,0.000010388324,0.82936853,0.00040280772,0.0018147482,0.0001306643,0.011648254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973654,0.0002259231,0.00048310353,0.0011111585,0.0001443284,0.0006700574],"domain_scores_gemma":[0.9973902,0.001807006,0.00026167618,0.00036196894,0.0001181045,0.000061053666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000086150365,0.0005518917,0.0010026656,0.00042064406,0.00028723644,0.00019338961,0.00031182668,0.0006953528,0.0000057724665],"category_scores_gemma":[0.0013817208,0.00052169454,0.0002244248,0.00014251955,0.00044954199,0.0012574223,0.00024248268,0.0011171019,0.000007921066],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090362213,0.00015929283,0.0004288513,0.00029926086,0.0004338416,0.000005751965,0.002467206,0.0000042684283,0.000120372955,0.0003305127,0.99293536,0.0019116623],"study_design_scores_gemma":[0.0019324623,0.000101991216,0.001901082,0.0004279235,0.0002621098,0.0000017422715,0.011769733,0.000005904266,0.000024147355,0.0018214004,0.98116106,0.0005904686],"about_ca_topic_score_codex":0.00019829812,"about_ca_topic_score_gemma":0.0007080342,"teacher_disagreement_score":0.049670383,"about_ca_system_score_codex":0.00023208489,"about_ca_system_score_gemma":0.00024378928,"threshold_uncertainty_score":0.99972343},"labels":[],"label_agreement":null},{"id":"W4391650116","doi":"10.3389/fddsv.2024.1336025","title":"Machine learning in toxicological sciences: opportunities for assessing drug toxicity","year":2024,"lang":"en","type":"article","venue":"Frontiers in Drug Discovery","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Drug; Toxicity; Engineering ethics; Pharmacology; Medicine; Engineering; Internal medicine","score_opus":0.06653782804313975,"score_gpt":0.3324204777920456,"score_spread":0.26588264974890585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391650116","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19804901,0.0029405486,0.79052323,0.0026848037,0.002583681,0.00033987264,0.00001999584,0.00021070863,0.0026481326],"genre_scores_gemma":[0.7890287,0.00015493699,0.208412,0.00045759423,0.00012483905,0.00010044036,0.000022750055,0.000023187937,0.0016755423],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968903,0.0006071894,0.0005279068,0.0008921189,0.0004901053,0.0005923489],"domain_scores_gemma":[0.9981743,0.0013693246,0.00009021368,0.00025064652,0.000030949883,0.00008455533],"candidate_categories":["metaepi_narrow","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0034093198,0.00027359795,0.00040607783,0.0008311409,0.00021896225,0.0016927944,0.0010738936,0.00007691178,0.0000046601517],"category_scores_gemma":[0.00040571342,0.00025043052,0.00016348268,0.0012152195,0.00026630543,0.0043234318,0.0004909356,0.0004933375,0.0000022486252],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006781141,0.0004889931,0.030809434,0.00048109275,0.00006114815,0.000570537,0.0046141385,0.4778519,0.00027344457,0.29333973,0.017718632,0.17372313],"study_design_scores_gemma":[0.00030740598,0.00003974385,0.001927528,0.00023929222,0.0000060100456,0.0000104751825,0.00151882,0.91611737,0.0004082166,0.07309002,0.0059701907,0.00036491148],"about_ca_topic_score_codex":0.00006844655,"about_ca_topic_score_gemma":0.00005573006,"teacher_disagreement_score":0.5909797,"about_ca_system_score_codex":0.00040452374,"about_ca_system_score_gemma":0.00070662756,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null}]}